Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Hikari Heights-Varus Co's Net Margin % or its related term are showing as below:
SSE:2137'
s Net Margin % Range Over the Past 10 Years
Min: -10.4 Med: 2.8 Max: 7.05
Current: -10.4
SSE:2137's Net Margin % is ranked worse than 76.99% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs SSE:2137: -10.40
Hikari Heights-Varus Co (SSE:2137) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Hikari Heights-Varus Co Net Margin % Related Terms
Hikari Heights-Varus Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSE:2137 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Hikari Heights-Varus Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hikari Heights-Varus Co Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hikari Heights-Varus Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Hikari Heights-Varus Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hikari Heights-Varus Co (SSE:2137) has a Net Margin % of -6.62% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Hikari Heights-Varus Co and its competitors. According to the industry distribution chart, Hikari Heights-Varus Co ranks #512 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 77%.
Is Hikari Heights-Varus Co's Net Margin % too high?
Hikari Heights-Varus Co's current Net Margin % is -6.62%. Based on the distribution chart, Hikari Heights-Varus Co ranks #512 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hikari Heights-Varus Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hikari Heights-Varus Co's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hikari Heights-Varus Co ranks #512 out of 665 companies for Net Margin %. This places Hikari Heights-Varus Co in the lower half of its industry. The industry median Net Margin % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Hikari Heights-Varus Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hikari Heights-Varus Co's current Net Margin % is -6.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikari Heights-Varus Co stock overvalued right now?
Based on GuruFocus' analysis, Hikari Heights-Varus Co (SSE:2137) is currently considered Fairly Valued. The stock's GF Value™ is 円730.38, compared to a current price of 円700.00 — trading 4.2% below its estimated fair value. The current Net Margin % is -6.62%. Hikari Heights-Varus Co's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Hikari Heights-Varus Co (SSE:2137), the current Net Margin % is -6.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hikari Heights-Varus Co (SSE:2137) Overvalued in 2026?
Based on GuruFocus' analysis, Hikari Heights-Varus Co stock appears to be undervalued.
The current stock price of 円700.00 is trading 4.2% below its estimated GF Value™ of 円730.38.
GuruFocus considers Hikari Heights-Varus Co to be Fairly Valued.
Key valuation signals for SSE:2137:
Net Margin %: -6.62%
GF Value™: 円730.38 vs. price of 円700.00 (4.2% below fair value)
No single metric tells the full story. See the SSE:2137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hikari Heights-Varus Co Ltd is a Japanese firm engaged in operating senior homes. It operates nursing homes for the elderly. The company provides rooms for healthy elderly as well as ones requiring assisted living.
58GF Score
Get the complete analysis for SSE:2137
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSE:2137 has been successfully added to your 
